Mosaic Financial Group »

Kymera Therapeutics shares owned by Mosaic Financial Group

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Mosaic Financial Group from 13F filings

Historical chart of Mosaic Financial Group investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Mosaic Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Mosaic Financial Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $225k 2.9k 77.85

More positions owned by Mosaic Financial Group

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Specialized Funds Div App Etf (VIG)
Microsoft Corporation (MSFT)
Union Pacific Corporation (UNP)
Apple (AAPL)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
At&t (T)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Pimco Etf Tr Multisector Bd (PYLD)
Vanguard Index Fds Total Stk Mkt (VTI)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Eli Lilly & Co. (LLY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Broadcom (AVGO)

View all positions for Mosaic Financial Group

Top funds holding Kymera Therapeutics

venBio Select Advisor
Baker Bros. Advisors
Vanguard Group
FMR
BVF
Wellington Management Company
BlackRock
Atlas Venture Life Science Advisors
Siren
State Street Corporation
Capital Research Global Investors
Geode Capital Management
Driehaus Capital Management
Ubs Global Asset Management Americas
Merck & Co

View all funds holding Kymera Therapeutics